Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2008, Article ID 281536, 5 pages
http://dx.doi.org/10.1155/2008/281536
Review Article

C-Peptide Effects on Renal Physiology and Diabetes

UPRES EA 21-93, Laboratoire de Diabétologie, Faculté de Médecine de Marseille, Université de la Méditerranée, 13385 Marseille Cedex 05, France

Received 1 November 2007; Accepted 10 April 2008

Academic Editor: Thomas Forst

Copyright © 2008 L. Rebsomen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. King and M. Brownlee, “The cellular and molecular mechanisms of diabetic complications,” Endocrinology and Metabolism Clinics of North America, vol. 25, no. 2, pp. 255–270, 1996. View at Publisher · View at Google Scholar
  2. D. F. Steiner, “Evidence for a precursor in the biosynthesis of insulin,” Transactions of the New York Academy of Sciences, vol. 30, no. 1, pp. 60–68, 1967. View at Google Scholar
  3. D. F. Steiner, “Proinsulin and the biosynthesis of insulin,” The New England Journal of Medicine, vol. 280, no. 20, pp. 1106–1113, 1969. View at Google Scholar
  4. D. F. Steiner, “Proinsulin,” Triangle, vol. 11, no. 2, pp. 51–60, 1972. View at Google Scholar
  5. B.-L. Johansson, S. Sjoberg, and J. Wahren, “The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients,” Diabetologia, vol. 35, no. 2, pp. 121–128, 1992. View at Publisher · View at Google Scholar
  6. B.-L. Johansson, B. Linde, and J. Wahren, “Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients,” Diabetologia, vol. 35, no. 12, pp. 1151–1158, 1992. View at Publisher · View at Google Scholar
  7. B.-L. Johansson, A. Kernell, S. Sjoberg, and J. Wahren, “Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1,” Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 4, pp. 976–981, 1993. View at Publisher · View at Google Scholar
  8. B.-L. Johansson, K. Borg, E. Fernqvist-Forbes, T. Odergren, S. Remahl, and J. Wahren, “C-peptide improves autonomic nerve function in IDDM patients,” Diabetologia, vol. 39, no. 6, pp. 687–695, 1996. View at Publisher · View at Google Scholar
  9. B.-L. Johansson, K. Borg, E. Fernqvist-Forbes, A. Kernell, T. Odergren, and J. Wahren, “Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus,” Diabetic Medicine, vol. 17, no. 3, pp. 181–189, 2000. View at Publisher · View at Google Scholar
  10. A. Djemli-Shipkolye, P. Gallice, T. Coste et al., “The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients,” Metabolism, vol. 49, no. 7, pp. 868–872, 2000. View at Publisher · View at Google Scholar · View at PubMed
  11. D. D. de La Tour, D. Raccah, M. F. Jannot, T. Coste, C. Rougerie, and P. Vague, “Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level,” Diabetologia, vol. 41, no. 9, pp. 1080–1084, 1998. View at Publisher · View at Google Scholar
  12. A. Djemli-Shipkolye, T. Coste, D. Raccah, P. Vague, G. Pieroni, and A. Gerbi, “Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters,” Cellular and Molecular Biology, vol. 47, no. 2, pp. 297–304, 2001. View at Google Scholar
  13. T. Forst, D. D. de La Tour, T. Kunt et al., “Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type I,” Clinical Science, vol. 98, no. 3, pp. 283–290, 2000. View at Publisher · View at Google Scholar
  14. P. Fiorina, F. Folli, P. Maffi et al., “Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation,” Transplantation, vol. 75, no. 8, pp. 1296–1301, 2003. View at Publisher · View at Google Scholar · View at PubMed
  15. P. Fiorina, F. Folli, F. Bertuzzi et al., “Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients,” Diabetes Care, vol. 26, no. 4, pp. 1129–1136, 2003. View at Publisher · View at Google Scholar
  16. R. Rigler, A. Pramanik, P. Jonasson et al., “Specific binding of proinsulin C-peptide to human cell membranes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13318–13323, 1999. View at Publisher · View at Google Scholar
  17. K. Lindström, C. Johansson, E. Johnsson, and B. Haraldsson, “Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat,” Acta Physiologica Scandinavica, vol. 156, no. 1, pp. 19–25, 1996. View at Publisher · View at Google Scholar
  18. Y. Ohtomo, A. Aperia, B. Sahlgren, B.-L. Johansson, and J. Wahren, “C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y,” Diabetologia, vol. 39, no. 2, pp. 199–205, 1996. View at Publisher · View at Google Scholar
  19. Y. Ohtomo, T. Bergman, B.-L. Johansson, H. Jörnvall, and J. Wahren, “Differential effects of proinsulin C-peptide fragments on Na+, K+- ATPase activity of renal tubule segments,” Diabetologia, vol. 41, no. 3, pp. 287–291, 1998. View at Publisher · View at Google Scholar
  20. M. Sjoquist, W. Huang, and B.-L. Johansson, “Effects of C-peptide on renal function at the early stage of experimental diabetes,” Kidney International, vol. 54, no. 3, pp. 758–764, 1998. View at Publisher · View at Google Scholar · View at PubMed
  21. B. Samnegård, S. H. Jacobson, G. Jaremko, B.-L. Johansson, and M. Sjöquist, “Effects of C-peptide on glomerular and renal size and renal function in diabetic rats,” Kidney International, vol. 60, no. 4, pp. 1258–1265, 2001. View at Publisher · View at Google Scholar · View at PubMed
  22. A. A. F. Sima, W. Zhang, K. Sugimoto et al., “C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat,” Diabetologia, vol. 44, no. 7, pp. 889–897, 2001. View at Publisher · View at Google Scholar
  23. P. Vague, T. C. Coste, M. F. Jannot, D. Raccah, and M. Tsimaratos, “C-peptide, Na+, K+-ATPase, and diabetes,” Experimental Diabesity Research, vol. 5, no. 1, pp. 37–50, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. J. Wahren, J. Shafqat, J. Johansson, A. Chibalin, K. Ekberg, and H. Jörnvall, “Molecular and cellular effects of C-peptide—new perspectives on an old peptide,” Experimental Diabesity Research, vol. 5, no. 1, pp. 15–23, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. P. Fiorina, M. Venturini, F. Folli et al., “Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation,” Diabetes Care, vol. 28, no. 6, pp. 1303–1310, 2005. View at Publisher · View at Google Scholar
  26. P. Fiorina, G. Perseghin, F. De Cobelli et al., “Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation,” Diabetes Care, vol. 30, no. 3, pp. 597–603, 2007. View at Publisher · View at Google Scholar · View at PubMed
  27. A. M. J. Shapiro, “Islet transplants and impact on secondary diabetic complications: does C-peptide protect the kidney?,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2214–2216, 2003. View at Publisher · View at Google Scholar
  28. L. Rebsomen, S. Pitel, F. Boubred et al., “C-peptide replacement improves weight gain and renal function in diabetic rats,” Diabetes & Metabolism, vol. 32, no. 3, pp. 223–228, 2006. View at Publisher · View at Google Scholar
  29. A. Kamikawa, T. Ishii, K. Shimada et al., “Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats,” Diabetes/Metabolism Research and Reviews, vol. 24, no. 4, pp. 331–338, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. L. Nordquist, E. Y. Lai, M. Sjöquist, A. Patzak, and A. E. G. Persson, “Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism,” American Journal of Physiology, vol. 294, no. 3, pp. R835–R841, 2008. View at Publisher · View at Google Scholar · View at PubMed
  31. L. Nordquist, E. Moe, and M. Sjöquist, “The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats,” Diabetes/Metabolism Research and Reviews, vol. 23, no. 5, pp. 400–405, 2007. View at Publisher · View at Google Scholar · View at PubMed
  32. S. C. Thomson, A. Deng, D. Bao, J. Satriano, R. C. Blantz, and V. Vallon, “Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes,” Journal of Clinical Investigation, vol. 107, no. 2, pp. 217–224, 2001. View at Publisher · View at Google Scholar · View at PubMed
  33. S. C. Thomson, V. Vallon, and R. C. Blantz, “Kidney function in early diabetes: the tubular hypothesis of glomerular filtration,” American Journal of Physiology, vol. 286, no. 1, pp. F8–F15, 2004. View at Publisher · View at Google Scholar · View at PubMed
  34. H. Wald and M. M. Popovtzer, “The effect of streptozotocin-induced diabetes mellitus on urinary excretion of sodium and renal Na+-K+-ATPase activity,” Pflugers Archiv European Journal of Physiology, vol. 401, no. 1, pp. 97–100, 1984. View at Publisher · View at Google Scholar
  35. M. Tsimaratos, “Physiological effects of the connecting peptide,” Archives de Pediatrie, vol. 12, no. 4, pp. 442–448, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. T.-H. Kwon, J. Nielsen, Y.-H. Kim, M. A. Knepper, J. Frøkiaer, and S. Nielsen, “Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II,” American Journal of Physiology, vol. 285, no. 1, pp. F152–F165, 2003. View at Google Scholar
  37. P. Bardoux, P. Bruneval, D. Heudes, N. Bouby, and L. Bankir, “Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats,” Nephrology Dialysis Transplantation, vol. 18, no. 9, pp. 1755–1763, 2003. View at Publisher · View at Google Scholar
  38. E. Féraille and A. Doucet, “Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control,” Physiological Reviews, vol. 81, no. 1, pp. 345–418, 2001. View at Google Scholar
  39. M. Tsimaratos, F. Roger, D. Chabardès et al., “C-peptide stimulates Na+, K+-ATPase activity via PKC alpha in rat medullary thick ascending limb,” Diabetologia, vol. 46, no. 1, pp. 124–131, 2003. View at Publisher · View at Google Scholar · View at PubMed
  40. M. Tsimarato, T. C. Coste, A. Djemli-Shipkolye et al., “Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats,” Cellular and Molecular Biology, vol. 47, no. 2, pp. 239–245, 2001. View at Google Scholar
  41. D. Raccah, M. F. Lamotte-Jannot, T. Issautier, and P. Vague, “Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney,” Diabetes & Metabolism, vol. 20, no. 3, pp. 271–274, 1994. View at Google Scholar
  42. D. Raccah, T. Coste, N. E. Cameron, D. Dufayet, P. Vague, and T. C. Hohman, “Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats,” Journal of Diabetes and Its Complications, vol. 12, no. 3, pp. 154–162, 1998. View at Publisher · View at Google Scholar
  43. S. F. Leong and T. K. C. Leung, “Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain,” Neurochemical Research, vol. 16, no. 10, pp. 1161–1165, 1991. View at Publisher · View at Google Scholar
  44. Y.-C. Ng, P. H. Tolerico, and C.-B. Book, “Alterations in levels of Na+-K+-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats,” American Journal of Physiology, vol. 265, no. 2, part 1, pp. E243–E251, 1993. View at Google Scholar
  45. P. Öner, B. Öztaş, and H. Koçak, “Brain cortex Na+-K+ ATPase activities in streptozotocin-diabetic and pentylenetetrazol-epileptic rats,” Pharmacological Research, vol. 36, no. 1, pp. 69–72, 1997. View at Publisher · View at Google Scholar · View at PubMed
  46. A. Ottlecz, C. A. Garcia, J. Eichberg, and D. A. Fox, “Alterations in retinal Na+, K+-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats,” Current Eye Research, vol. 12, no. 12, pp. 1111–1121, 1993. View at Publisher · View at Google Scholar
  47. T. Ohara, K. E. Sussman, and B. Draznin, “Effect of diabetes on cytosolic free Ca2+ and Na+-K+-ATPase in rat aorta,” Diabetes, vol. 40, no. 11, pp. 1560–1563, 1991. View at Publisher · View at Google Scholar
  48. R. Komers and S. Anderson, “Paradoxes of nitric oxide in the diabetic kidney,” American Journal of Physiology, vol. 284, no. 6, pp. F1121–F1137, 2003. View at Google Scholar
  49. N. M. Al-Rasheed, R. S. Chanai, R. J. Baines, G. B. Willars, and N. J. Brunskill, “Ligand-independent activation of peroxisome proliferator-activated receptor-γ by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 49747–49754, 2004. View at Publisher · View at Google Scholar · View at PubMed
  50. M. Kitazawa, Y. Shibata, S. Hashimoto, Y. Ohizumi, and T. Yamakuni, “Proinsulin C-peptide stimulates a PKC/IκB/NF-κB signaling pathway to activate COX-2 gene transcription in Swiss 3T3 fibroblasts,” Journal of Biochemistry, vol. 139, no. 6, pp. 1083–1088, 2006. View at Publisher · View at Google Scholar · View at PubMed
  51. Y. Maezawa, K. Yokote, K. Sonezaki et al., “Influence of C-peptide on early glomerular changes in diabetic mice,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 4, pp. 313–322, 2006. View at Publisher · View at Google Scholar · View at PubMed
  52. M. Tsimaratos, T. C. Coste, A. Djemli-Shipkolye, P. Vague, G. Pieroni, and D. Raccah, “γ-linolenic acid restores renal medullary thick ascending limb Na+, K+-ATPase activity in diabetic rats,” Journal of Nutrition, vol. 131, no. 12, pp. 3160–3165, 2001. View at Google Scholar
  53. W. Wang, F. Liu, and N. Chen, “Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists attenuate the profibrotic response induced by TGF-β1 in renal interstitial fibroblasts,” Mediators of Inflammation, vol. 2007, Article ID 62641, 7 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
  54. M. G. Vish, P. Mangeshkar, G. Piraino et al., “Proinsulin C-peptide exerts beneficial effects in endotoxic shock in mice,” Critical Care Medicine, vol. 35, no. 5, pp. 1348–1355, 2007. View at Publisher · View at Google Scholar · View at PubMed